TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
OTLK

OUTLOOK THERAPEUTICS INC

Healthcare · Biotechnology

0.681$ +0.6% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns OUTLOOK THERAPEUTICS INC (OTLK)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 80.6% of the shares are freely tradable; institutional investors hold 6.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 6.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 17.4%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 80.6%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 14.4%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 243Mio.

Largest Shareholders

Institutions

Institutions OTLK
Name Stake (%) Shares Change (%) Date
Armistice Capital, LLC 1.72 4,168,000 +0.0 03/31/2026
Perceptive Advisors LLC 1.29 3,139,216 +0.0 06/30/2026
Vanguard Capital Management, LLC 0.81 1,967,160 +0.0 03/31/2026
Geode Capital Management, LLC 0.25 603,606 +90.7 03/31/2026
GILPIN WEALTH MANAGEMENT, LLC 0.23 555,000 -7.5 06/30/2026
BlackRock Inc 0.20 477,471 +18.0 03/31/2026
Renaissance Technologies Corp 0.11 255,157 +0.0 03/31/2026

Funds

Funds OTLK
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 1.26 3,069,295 +0.0 07/31/2026
Vanguard Institutional Extnd Mkt Idx Tr 0.51 1,231,851 +0.0 07/31/2026
Fidelity Extended Market Index 0.22 529,168 -4.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings OTLK
Person Role Shares Value As of Type
Sukhtian Ghiath M. Director 24,617,320 16,764,395 $ Aug 12, 2026 indirect
Sukhtian Faisal Ghiath Director 220,972 150,482 $ Jul 29, 2026 direct
Jahr Robert Charles Chief Executive Officer 151,515 103,182 $ Aug 14, 2026 direct
Kenyon Lawrence A Chief Financial Officer 106,956 72,837 $ Aug 14, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Aug 14, 2026 Kenyon Lawrence A Chief Financial Officer Buy 101,010
Aug 14, 2026 Jahr Robert Charles Chief Executive Officer Buy 151,515
Aug 12, 2026 Sukhtian Ghiath M. Director Buy 2,525,252 0.99 2,499,999
Jul 29, 2026 Sukhtian Faisal Ghiath Director Buy 95,398 1.05 99,996

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?